← Browse by Condition
Medical Condition

radiotherapy side effect

Total Trials
8
Recruiting Now
8
Trial Phases
Phase 2

ClinicalMetric tracks all active clinical trials for radiotherapy side effect sourced from ClinicalTrials.gov. Research in this area spans early-phase safety investigations through large Phase 3 confirmatory trials, conducted by NIH-funded academic centers, independent investigators, and pharmaceutical sponsors worldwide. Each listing is updated daily as new studies open enrollment and existing ones reach capacity or complete follow-up.

Trial listings include the NCT identifier, current recruitment status, phase classification, primary and secondary endpoints, estimated enrollment size, participating countries, and direct links to the full protocol on ClinicalTrials.gov. Eligibility criteria — including age range, disease stage, and prior treatment requirements — are documented for every study to help patients and clinicians assess suitability before contacting a trial site.

Frequently Asked Questions — radiotherapy side effect Clinical Trials

How many clinical trials are currently recruiting for radiotherapy side effect?
ClinicalMetric currently tracks 8 actively recruiting clinical trials for radiotherapy side effect, sourced in real time from ClinicalTrials.gov. The total number of registered studies—including those not yet enrolling or in active follow-up—is 8. Trial availability changes daily as new studies open enrollment and existing ones reach capacity.
What trial phases are available for radiotherapy side effect?
radiotherapy side effect research spans Phase 2 (1 trial). Phase 1 studies evaluate safety and dosing in small groups, Phase 2 studies assess preliminary efficacy in 100–300 participants, and Phase 3 trials compare the new treatment against the standard of care in 300–3,000+ patients. Phase 4 post-approval studies monitor long-term outcomes in real-world populations.
How do I find out if I qualify for a radiotherapy side effect clinical trial?
Eligibility criteria for radiotherapy side effect trials vary by study and typically specify age range, disease stage or severity, prior treatment history, and specific diagnostic or laboratory parameters. Each listing on ClinicalMetric links to the full protocol on ClinicalTrials.gov, where inclusion and exclusion criteria are documented. Contact the sponsoring site's research coordinator directly to confirm your eligibility—your treating physician or specialist can also help identify the most appropriate trial based on your medical history and current treatment status.
Trial Phases
Phase 2
1
Top Sponsors
University of Aarhus 2 trials
Karolinska University Hospital 1 trial
Oslo University Hospital 1 trial
University Hospital, Angers 1 trial
Samsung Medical Center 1 trial

Recruiting Clinical Trials

NCT05724004
Recruiting
Alectinib Followed by Concomitant Consolidation Radiation Therapy in Advanced NSCLC With ALK-rearrangement (A-SAB)
Enrollment
70 pts
Location
Sweden
Sponsor
Karolinska University Hospital
View Trial →
NCT06297902
Recruiting
RAdiotherapy With FDG-PET Guided Dose-PAINTing Compared With Standard Radiotherapy for Primary Head and Neck Cancer-3
Enrollment
100 pts
Location
Norway
Sponsor
Oslo University Hospital
View Trial →
NCT06618703
Recruiting
Brain Irradiation for Childhood Cancer - Endocrine Monitoring During the First Years
Enrollment
230 pts
Location
France
Sponsor
University Hospital, Angers
View Trial →
NCT06950073
Recruiting
Curatively Intended Thoracic Reirradiation
Enrollment
500 pts
Location
Denmark
Sponsor
University of Aarhus
View Trial →
NCT05775757
Recruiting
SMC Radiation Oncology Breast Cancer Cohort Study
Enrollment
500 pts
Location
South Korea
Sponsor
Samsung Medical Center
View Trial →
NCT05762900 Phase 2
Recruiting
Ultra-hypofractioNated Adjuvant Radiotherapy ± sImultaneous Integrated Boost for Low-risk Breast Cancer Patients
Enrollment
65 pts
Location
China
Sponsor
Cancer Institute and Hospital,...
View Trial →
NCT03742687
Recruiting
Heterogeneously Hypofractionated Radiotherapy for Locally Advanced NSCLC
Enrollment
151 pts
Location
Denmark
Sponsor
Danish Lung Cancer Group
View Trial →
NCT05350475
Recruiting
Protons Vs. Photons for High-risk Prostate Cancer
Enrollment
400 pts
Location
Denmark
Sponsor
University of Aarhus
View Trial →

Related Conditions

non small cell lung cancer (1) alk gene mutation (1) head and neck cancer (1) endocrine deficiency (1) hypothalamo pituitary disorder (1) radiation toxicity (1) oncology (1) lung cancer (1) thoracic cancer (1) breast cancer (1) stage iii non small cell lung cancer (1) stage iv non small cell lung cancer (1)
ClinicalMetric — Independent clinical trial intelligence platform. Not affiliated with NIH, ClinicalTrials.gov, the U.S. FDA, or any pharmaceutical company, hospital, or clinical research organization. Trial data is sourced from ClinicalTrials.gov for informational purposes only and does not constitute medical advice. Do not make any treatment, enrollment, or health decisions based solely on information found here — always consult a qualified healthcare professional. Full Disclaimer  ·  Last Reviewed: July 2026  ·  Data Methodology